COCH MEXC RealStocks
Own real COCH shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-13 16:47:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Envoy Medical, Inc. (COCH) operates in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector and is listed on NASDAQ. The stock is currently priced at $6.73, with a market capitalization of $52.74M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.63 to $9.54. This page covers its latest market performance, valuation, price trends and company information.
$52.74M | |
$6.76 | |
$6.80 | |
$6.72 | |
$6.81 | |
4.27K | |
15.26K | |
-- | |
$9.54 | |
$3.63 | |
-- | |
-- |
Envoy Medical, Inc. (COCH) is currently trading at $6.73 as of 2026-11-13 16:43:00, down 0.44% ($0.03) from the previous close of $6.81
During today's regular trading session, COCH has traded between $6.72 and $6.80, with a trading volume of 4.27K shares. The current price is near the lower end of today's range.
Over the past seven days, Envoy Medical, Inc. (COCH) moved from $7.12 to $6.73, representing a decline of 5.48% ($0.39).
The stock traded between $6.55 and $7.46 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 43.21 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 52.5%
COCH is currently trading at $6.73, placing it 52.5% of the way from its 52-week low of $3.63 to its 52-week high of $9.54. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
| Industry | ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES |
| Employees | 47 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Envoy Medical, Inc. (COCH) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to COCH, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between COCH shares and USD.
COCH Shares to USD
1.00 COCH shares = 6.73 USD
Calculations are estimates based on the latest available price and are for reference only.